Friday, 18 Jan 2019

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

Dr. Jack Cush: Fewer Rheumatologists (...

13 Nov 2016

The RheumNow Week in Review - 5 January...

05 Jan 2018

Dr. Paul Sufka: Pregnancy and Treatment

07 Nov 2017

Dr. Cassie Calabrese: Gout

23 Oct 2018

Dr. Jeffrey Chwa: A "Large"...

09 Feb 2018

Dr. Cassie Calabrese: RA Paradigm...

17 Jul 2017

Dr. Arthur Kavanaugh: Summarizing ACR...

16 Nov 2016

Dr. Olga Petryna: FRAME Study

05 Nov 2017

4 Contraindications to TNF Inhibitor Use

03 Oct 2016

Dr Jack Cush: Stills and Auto-...

08 Nov 2017

The RheumNow Week in Review - 9 March...

09 Mar 2018

Dr. Jack Cush: Highlights from 2017 in...

09 Feb 2018